Impact BioMedical, Inc. Long-term Investment Intensity
Impact BioMedical, Inc. long-term investment intensity. Impact BioMedical, Inc. (IBO) has a Long-term Investment Intensity of 1.7% as of June 2023. Long-term investments of $782.00K represent 1.7% of total assets of $45.99 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read IBO liabilities breakdown for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Impact BioMedical, Inc. (2020–2022)
Long-term investment intensity of Impact BioMedical, Inc. from 2020 to 2022. This chart shows how Impact BioMedical, Inc.'s Long-term Investment Intensity has evolved across 3 annual periods from 2020 to 2022. As of June 2023, the intensity stands at 1.7%, reflecting long-term investments of $782.00K against total assets of $45.99 Million USD.
Impact BioMedical, Inc. Long-term Investment Intensity by Year (2020–2022)
Impact BioMedical, Inc. long-term investment intensity by year from 2020 to 2022. The table below presents the year-by-year Long-term Investment Intensity for Impact BioMedical, Inc. from 2020 to 2022, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see IBO total assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 1.7% | $782.00K | $46.50 Million | ▼ -119.0 pp |
| 2021 | 120.7% | $4.82 Million | $3.99 Million | ▼ -748.3 pp |
| 2020 | 868.9% | $632.10K | $72.74K | — |